IRADIMED Corporation

Robbins Arroyo LLP Is Investigating the Officers and Directors of IRADIMED Corporation (IRMD) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of IRADIMED Corporation (NasdaqCM: IRMD) breached their fiduciary duties to shareholders. IRADIMED develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally.

IRADIMED Receives Warning Letter from the U.S. Food and Drug Administration

On September 3, 2014, shares of IRADIMED dropped over 31% to close at $7.15 per share after the company announced that it received a warning letter from the U.S. Food and Drug Administration in relation to an inspection that took place in April 2014. Among other things, the warning letter requires a new submission for the company’s IV infusion pump systems, mRidium 3860 and mRidium 3850, because of the periodic software updates. The IV pumps were previously cleared, but according the warning letter such updates are “significant” changes that could affect safety and effectiveness of the product. In addition to the submissions, the warning letter requires that the mRidium 3860+ infusion pump receive separate FDA approval.

IRADIMED Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003,or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *
E-mail * Confirm: E-mail *

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Shares Sold:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: